Atomo Diagnostics Limited (ASX:AT1)
Australia · Delayed Price · Currency is AUD 0.0410
+0.0030 (7.89%)
Feb 26, 2026, 3:11 PM AEST
Atomo Diagnostics Market Cap
Atomo Diagnostics has a market cap or net worth of 30.79 million as of February 25, 2026. Its market cap has increased by 153.50% in one year.
Market Cap
30.79M
Enterprise Value
27.75M
Revenue
3.79M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since April 16, 2020, Atomo Diagnostics's market cap has decreased from 218.82M to 30.79M, a decrease of -85.93%. That is a compound annual growth rate of -28.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 30.79M | 5.56% |
| Dec 31, 2025 | 29.17M | 140.15% |
| Dec 31, 2024 | 12.14M | -13.64% |
| Dec 29, 2023 | 14.06M | -54.38% |
| Dec 30, 2022 | 30.83M | -81.93% |
| Dec 31, 2021 | 170.58M | -1.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Compumedics | 67.92M |
| Micro-X | 50.83M |
| CleanSpace Holdings | 46.14M |
| Nova Eye Medical | 45.57M |
| HeraMED | 41.21M |
| CurveBeam AI | 32.96M |
| ImpediMed | 32.62M |
| Control Bionics | 24.61M |